HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study

High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients

(2020) Sara Sokooti et al.   Biomolecules

Bariatric Surgery Improves HDL Function Examined by ApoA1 Exchange Rate and Cholesterol Efflux Capacity in Patients with Obesity and Type 2 Diabetes

(2020) Shuhui Wang Lorkowski et al.   Biomolecules

Associations Between HDL Particles and Ischemic Events by Vascular Domain, Gender, and Ethnicity: A Pooled Cohort Analysis

(2020) Kavisha Singh et al.   CIRCULATION

Role of HDL function and LDL atherogenicity on cardiovascular risk: A comprehensive examination

(2019) Álvaro Hernáez et al.   PLoS One

Therapy with cholesteryl ester transfer protein (CETP) inhibitors and diabetes risk

(2018) W. Masson et al.   DIABETES & METABOLISM

PCSK9 deficiency reduces insulin secretion and promotes glucose intolerance: the role of the low-density lipoprotein receptor

(2018) Lorenzo Da Dalt et al.   EUROPEAN HEART JOURNAL

Higher plasma GlycA, a novel pro-inflammatory glycoprotein biomarker, is associated with reduced life expectancy: The PREVEND study

(2018) Eke G. Gruppen et al.   CLINICA CHIMICA ACTA

Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker

(2018) Annika M. A. Berends et al.   CLINICAL ENDOCRINOLOGY

Lipoprotein insulin resistance index, a high-throughput measure of insulin resistance, is associated with incident type II diabetes mellitus in the Prevention of Renal and Vascular End-Stage Disease study

(2018) Jose L. Flores-Guerrero et al.   Journal of Clinical Lipidology

Obesity and dyslipidemia

(2018) Jelena Vekic et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease

(2017) W. Sean Davidson et al.   JOURNAL OF LIPID RESEARCH

HDL efflux capacity, HDL particle size, and high-risk carotid atherosclerosis in a cohort of asymptomatic older adults: the Chicago Healthy Aging Study

(2017) R. Kannan Mutharasan et al.   JOURNAL OF LIPID RESEARCH

Incident type 2 diabetes is associated with HDL, but not with its anti-oxidant constituent - paraoxonase-1: The prospective cohort PREVEND study

(2017) Setor K. Kunutsor et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Paraoxonase-1 activity is positively related to phospholipid transfer protein activity in type 2 diabetes mellitus: Role of large HDL particles

(2016) Robin P.F. Dullaart et al.   CLINICAL BIOCHEMISTRY

The utility of diabetes risk score items as predictors of incident type 2 diabetes in Asian populations: An evidence-based review

(2016) Pei Lin Hu et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Weight loss surgery in adolescents corrects high-density lipoprotein subspecies and their function

(2016) W S Davidson et al.   INTERNATIONAL JOURNAL OF OBESITY

High-density lipoprotein and inflammation in cardiovascular disease

(2016) Margery A. Connelly et al.   Translational Research

Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study

(2016) Wijtske Annema et al.   Scientific Reports

Inverse linear associations between liver aminotransferases and incident cardiovascular disease risk: The PREVEND study

(2015) Setor K. Kunutsor et al.   ATHEROSCLEROSIS

Phospholipid transfer protein activity and incident type 2 diabetes mellitus

(2015) Ali Abbasi et al.   CLINICA CHIMICA ACTA

HDL particle number measured on the Vantera®, the first clinical NMR analyzer

(2015) Steven P. Matyus et al.   CLINICAL BIOCHEMISTRY

Differential Association Between HDL Subclasses and the Development of Type 2 Diabetes in a Prospective Study of Japanese Americans

(2015) You-Cheol Hwang et al.   DIABETES CARE

High-density lipoprotein, beta cells, and diabetes

(2014) A. von Eckardstein et al.   CARDIOVASCULAR RESEARCH

Serum paraoxonase-1 activity is more closely related to HDL particle concentration and large HDL particles than to HDL cholesterol in Type 2 diabetic and non-diabetic subjects

(2014) Robin P.F. Dullaart et al.   CLINICAL BIOCHEMISTRY

Lipoprotein Insulin Resistance Index: A Lipoprotein Particle–Derived Measure of Insulin Resistance

(2014) Irina Shalaurova et al.   Metabolic Syndrome and Related Disorders

HDL Cholesterol Efflux Capacity and Incident Cardiovascular Events

(2014) Anand Rohatgi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids

(2013) Laurent Camont et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Gender aspects in type 2 diabetes mellitus and cardiometabolic risk

(2013) Naveed Sattar   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Role of HDL Cholesterol and Estimates of HDL Particle Composition in Future Development of Type 2 Diabetes in the General Population: The PREVEND Study

(2013) Ali Abbasi et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects

(2013) Robin P. F. Dullaart et al.   Obesity

New Roles of HDL in Inflammation and Hematopoiesis

(2012) Xuewei Zhu et al.   Annual Review of Nutrition

Pancreatic β-cell function relates positively to HDL functionality in well-controlled Type 2 diabetes mellitus

(2012) Robin P.F. Dullaart et al.   ATHEROSCLEROSIS

Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)

(2012) J. Lindström et al.   DIABETOLOGIA

The emerging role of HDL in glucose metabolism

(2012) Brian G. Drew et al.   Nature Reviews Endocrinology

Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome

(2011) Paul Jan Willem Herman Kappelle et al.   ARCHIVES OF MEDICAL RESEARCH

Plasma procalcitonin and risk of type 2 diabetes in the general population

(2011) A. Abbasi et al.   DIABETOLOGIA

Association of Lipid and Lipoprotein Profiles with Future Development of Type 2 Diabetes in Nondiabetic Korean Subjects: A 4-Year Retrospective, Longitudinal Study

(2011) Mi Hae Seo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

(2010) Margarita de la Llera-Moya et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Genetic Variation at the Phospholipid Transfer Protein Locus Affects Its Activity and High-Density Lipoprotein Size and Is a Novel Marker of Cardiovascular Disease Susceptibility

(2010) Menno Vergeer et al.   CIRCULATION

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women

(2010) S. Mora et al.   DIABETES

A functional ABCA1 gene variant is associated with low HDL-cholesterol levels and shows evidence of positive selection in Native Americans

(2010) Víctor Acuña-Alonzo et al.   HUMAN MOLECULAR GENETICS

Proteomic Characterization of Human Plasma High Density Lipoprotein Fractionated by Gel Filtration Chromatography

(2010) Scott M. Gordon et al.   JOURNAL OF PROTEOME RESEARCH

Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality

(2008) H. J. Lambers Heerspink et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Derangements of intravascular remodeling of lipoproteins in type 2 diabetes mellitus: Consequences for atherosclerosis development

(2008) Geesje M. Dallinga-Thie et al.   Current Diabetes Reports

NMR-determined lipoprotein subclass profile predicts type 2 diabetes

(2008) Allison M. Hodge et al.   DIABETES RESEARCH AND CLINICAL PRACTICE